Depression is a prevalent and costly mental disorder across all ages. Artificial intelligence (AI)-assisted physiological and behavioral information—such as electroencephalography (EEG), eye movement, video or audio monitoring, and gait analysis—offers a promising tool for…
Continue Reading
1. Deploy a Private Instance of an AI Tool
To secure AI in hospitals, Pete Johnson, CDW’s artificial intelligence field CTO, recommends using an in-house solution that lets clinicians and other staff experiment with an…
What You Should Know:
– Ryght AI, a leading AI clinical trial developer, today announced a partnership with Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies.
– The collaboration will bring advanced,…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ram Yalamanchili, Founder and CEO at Tilda Research. Tilda Research develops and…
Continue Reading
Wednesday 1 October 2025 | LondonDue to significant interest, Future of Health Europe will incorporate the inaugural AI in Health summit on Wednesday 1 October 2025. This summit will delve into how artificial intelligence…
Continue Reading
Background: Advances in artificial intelligence (AI) technology have raised new possibilities for the effective evaluation of daily dietary intake, but more empirical study is needed for the use of such technologies under realistic meal…
Continue Reading
I also look at the potential of AI-based technologies to make healthcare better and safer, by virtue of the fact that we can make care not episodic, and rather something that, like, walks with…
Continue Reading
What You Should Know:
– Better Medicine, an AI-powered diagnostic startup for radiology, has secured nearly €6M ($6.89M) in total funding. The company recently raised €1M ($1.1M) in a pre-seed funding round led by Soulmates…
Continue Reading
What You Should Know:
– Isaac Health, a leading health technology company for brain health and dementia care, announced today a $10.5 million Series A led by Flare Capital Partners, with participation from new investors, Industry…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
